tiragolumab,etoposide,serplulimab,atezolizumab,carboplatin,serplulimab
roche,fosun pharmaceuticals
['skyscraper-02', 'atezo', 'serplulimab', 'sclc']
oral session at #asco22: two phase 3 trials in es-sclc skyscraper-02 (chemo+atezo+antitigit) negative trial and astrum-005 (chemo+antipd-1 serplulimab) by dr. ying cheng positive trial: pd-1 vs pd-l1 effect? different patient populations usa vs asian? 
MD, PhD, Lead Thoracic Oncol. Unit @hospitalclinic, MedOnc, Prof. @unibarcelona, Researcher Transl Genom ?? Targeted Therapies @IDIBAPS, @EORTC @GECP_org, #LCSM